Parkinson's disease drugs that mimic dopamine inside the brain.

A group of drugs used to treat Parkinson's that work by stimulating the parts of the brain which use dopamine.

Medications with predominant effects on pituitary cells that harbor receptors for the chemical transmitter dopamine.

Dopamine agonists such as bromocriptine (brand name Parlodel) and cabergoline (brand name Dostinex) inhibit GH release from the tumor. They work by stimulating natural receptorsof the hormone dopamine on the surface of the tumor. This sends messages into the tumor cells to stop producing GH.

Drugs (for example, lisuride, bromocriptine, cabergoline, pergolide, and ropinirole) that stimulate dopamine receptors directly. They are often used in conjunction with levodopa to supplement its effect. They have a number of known side-effects, including nausea, vomiting, and sometimes severe psychiatric reactions – including hallucinations

Mimic the effects of dopamine without boosting body's production. This class of drugs is used to postpone levodopa therapy and its side effects.

Medications that attempt to mimic the role of dopamine in the brain.